Targeting DNA mismatches with metal complexes.

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Cancer Research

Background:

• DNA mismatches, non-canonical base pairs, arise from replication errors or DNA damage.
• The mismatch repair (MMR) pathway normally corrects these errors.
• MMR deficiency in cancers (e.g., colorectal, endometrial) leads to persistent DNA mismatches, creating a therapeutic vulnerability.

Purpose of the Study:

• To review the potential of metal complexes in targeting DNA mismatches.
• To explore the use of rhodium(III), ruthenium(II), and platinum(II) complexes for selective DNA mismatch binding.
• To discuss applications in next-generation therapeutics and imaging probes.

Main Methods:

• Review of existing literature on metal complexes and DNA interactions.
• Analysis of structural, electronic, and photophysical properties of metal complexes.
• Discussion of ligand design strategies for selective DNA binding.

Main Results:

• Metal complexes with rhodium(III), ruthenium(II), and platinum(II) centers can preferentially bind to DNA mismatches.
• These complexes offer opportunities for differentiating between canonical and mismatched DNA.
• Ligand design is crucial for achieving high selectivity and desired properties.

Conclusions:

• Metal complexes represent a promising foundation for developing novel therapeutics and imaging agents targeting DNA mismatches.
• Exploiting the unique properties of metal complexes can lead to highly selective agents for MMR-deficient cancers.
• Further research into metal complex-DNA interactions can advance precision medicine and diagnostics.